Editorial policy
How we source and review information
The information on this site is meant to be accurate, up to date and simple for you to verify. Below you will find where it comes from. You will also see the rules each page must pass before we publish it.
Where our information comes from
The general information about clinical research on this site comes from material the U.S. government has published. You may be reading it while weighing a Phase 3 cancer trial, so you should know where it starts. We rely on federal research institutes and health agencies. Three of them are the National Institutes of Health, the Office for Human Research Protections and the Food and Drug Administration.
You will find the sources for each page listed at the bottom of that page. Every link goes to a source we opened and checked ourselves. We go back and check those links again on a regular schedule.
How study listings are produced
The study listings you see, and the counts beside them, are drawn from ClinicalTrials.gov. That is the public study registry run by the U.S. National Library of Medicine. Part of each record appears here exactly as it was registered. We leave the wording untouched.
Only one kind of study appears on this website: studies in Phase 3, including combined Phase 2/3. The registry's coding of each study determines which ones those are. We do not make that call.
So you can judge how current a listing is, each one shows the date its data were processed. The most current source is always the study's own registry record. Each listing links to that record. Phase 3 Cancer Trials does not run the studies it lists. It is not affiliated with their sponsors.
Rules every page must pass
- We never say or hint that an investigational product is safe. We never say it works, either. Those questions are the reason a study is run.
- We make no promise that joining a study will help you. We make no promise that you will be eligible.
- We never open with payment. You will not find payment amounts on this site.
- We never push you, or anyone, to decide quickly.
- We do not offer medical advice.
Each rule follows what the U.S. Food and Drug Administration advises about recruiting people for studies. Every page on Phase 3 Cancer Trials goes through software that checks it against these rules first. If a page breaks one, it is not published.
How pages are written
Yes, AI writing tools help draft the pages on Phase 3 Cancer Trials. The tools draft from the sources you see listed on that page. After that, each draft goes through software that tests it against the rules set out above.
Corrections
Please tell us if you spot an error or something outdated on Phase 3 Cancer Trials. We take every report back to the original source and compare the two. When the page turns out to be mistaken, it gets corrected.
Who is responsible
Pioneer Research Group operates Phase 3 Cancer Trials. Learn more about who we are.
Sources and further reading
- Recruiting Study Subjects — Guidance for Institutional Review Boards and Clinical Investigators — U.S. Food and Drug Administration
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections